European Journal of Neurology

Papers
(The H4-Index of European Journal of Neurology is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
118
98
CCR5‐Δ32polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients92
Basal ganglia ischaemic infarction after thrombectomy: cognitive impairment at acute stage91
Advancements in targeted therapies for generalized acetylcholine receptor antibody positive myasthenia gravis: Beginnings of a paradigm shift90
Hearing impairment and development of parkinsonism and possible rapid eye movement sleep behaviour disorder: A CLSA prospective population‐based study89
Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis78
COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition73
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment68
Electroencephalography functional connectivity—A biomarker for painful polyneuropathy66
Correlation between patient‐reported manual ability and three objective measures of upper limb function in people with multiple sclerosis60
Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients57
Out‐of‐hospital versus in‐hospital status epilepticus: The role of etiology and comorbidities57
Ischaemic cerebral small vessel disease caused by adenosine deaminase 2 deficiency syndrome57
Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study56
Mirror therapy for unilateral neglect after stroke: A systematic review55
Issue Information54
The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective50
Structural correlations between brain magnetic resonance image‐derived phenotypes and retinal neuroanatomy50
Central nervous system crystal‐storing histiocytosis: A case report and literature review48
ePoster46
Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis45
Neuropathy in GAA‐FGF14 Late‐Onset Cerebellar Ataxia (SCA27B): Prevalence and Characteristics45
Neurovascular Involvement in Fibromuscular Dysplasia: A Clue for Reappraisal of Old Classifications44
Cost‐effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health‐related quality of life44
Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study44
Lessons from the past to understand the future44
Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease42
A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis42
Response to erenumab assessed by Headache Impact Test‐6 is modulated by genetic factors and arterial hypertension: An explorative cohort study42
Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report41
Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms41
Mindfulness or meditation therapy for Parkinson's disease: A systematic review and meta‐analysis of randomized controlled trials41
Long‐term MRI changes in a patient with Kelch‐like protein 11‐associated paraneoplastic neurological syndrome41
Clinical and Genetic Reassessment in Patients With Clinically Diagnosed Hereditary Polyneuropathy40
Risk factors, neuroimaging correlates and prognosis of the motoric cognitive risk syndrome: A population‐based comparison with mild cognitive impairment40
Prioritization process for European Academy of Neurology clinical practice guidelines40
Switching from ligand to receptor anti‐calcitonin gene‐related peptide (CGRP) antibodies or vice versa in non‐responders: A controlled cohort study40
Comparative features and outcomes of major neurological complications of COVID‐1940
0.57307291030884